Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05306951
Other study ID # PDED0121
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date March 1, 2022
Est. completion date December 31, 2022

Study information

Verified date May 2022
Source University of Padova
Contact Giulia Berti De Marinis, MD
Phone +390498212860
Email giulia.bertidemarinis@aopd.veneto.it
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The aims of this retrospective and monocentric observational study are: to describe patient characteristics and clinical management of patients with traumatic brain injury taking antiplatelet and/or anticoagulation drugs; to estimate the proportion of patients who suffer an adverse outcome; to assess the risk for serious events (intracranial haemorrhage, in-hospital mortality, need for surgery); to identify potential predictors of outcome and assess potential differences between anticoagulation and antiplatelet therapy. All patients with mild brain injury and anticoagulant or antiplatelet therapy who underwent a head computed tomography (CT) scan admitted to the emergency department (ED) of the University Hospital of Padova, Italy, from 01/01/2010 to 31/12/2020.


Description:

Background Mild traumatic brain injury (mTBI) is one of the most common occurrences at the emergency departments in Italy and worldwide constituting major health and socioeconomic issue all over the world. mTBI is defined as a patient reporting a Glasgow Coma Scale (GSC) score of 14-15, disorientation, amnesia and loss of consciousness. On the other hand, the patient population treated with anticoagulant or antiplatelet drug therapy is increasing: this therapy is prescribed to prevent thromboembolic complications of atrial fibrillation, deep venous thrombosis, and surgically placed cardiac valves, especially in the elderly population. Numerous studies suggested that mostly aged patients or those with comorbidities with mTBI on anticoagulant or antiplatelet drug therapy have a higher risk of developing a haemorrhagic complication; but there is a lack of evidence for patients on new anticoagulants and second-generation antiplatelet drugs regarding a higher risk for intracranial haemorrhage (ICH), ICH progression, or death. Several international guidelines have been developed for the management of traumatic brain injury and they all recommended performing brain computed tomography (CT) for patients with head trauma taking oral anticoagulant agents even in absence of any neurological symptoms. Nevertheless, there is no agreement about the correct timing for performing a head CT scan, the duration of observation before discharge from ED and the necessity of repeating a second CT scan at distance. National Institute for Health and Care Excellence (NICE) guidelines 2014 recommend performing a CT scan within 8 hours of the injury for patients on anticoagulant therapy with mTBI and no other neurological symptoms, while European Federation of the Neurological Societies (EFNS) guidelines 2008 and New South Wales (NSW) guidelines 2011 recommend observation for 24 h and considering a second CT scan. A recent meta-analysis has collected 24 significant studies investigating the incidence of delayed intracranial haemorrhage in patients presenting with mTBI and anticoagulant or antiplatelet drug therapy: as far as anticoagulant drug therapy is concerned, only 2 studies regarding patients on double oral anticoagulation (DOAC) and 14 studies regarding patients on Vitamine K Antagonists (VKA) were identified. The incidence of delayed intracranial haemorrhage in both groups was the same (1.3%) and no difference was found between patients on DOAC who underwent a single CT scan and a repeated one after observation. Main objective To describe patient characteristics and clinical management of patients with a head injury during antithrombotic therapy To assess the risk for serious events (intracranial haemorrhage, death for traumatic brain injury, need for surgery) in patients on anticoagulant therapy and/or antiplatelet drugs who underwent a head CT scan following head injury. To identify potential predictors of outcome and assess potential differences between anticoagulation and antiplatelet therapy. Study design Retrospective, single centre non-interventional study of all patients admitted to the emergency department (ED) of the University Hospital of Padova, Italy, from 01/01/2010 to 31/12/2020, for traumatic brain injury. All patients on anticoagulant therapy and antiplatelet drugs who underwent a head CT scan will be enrolled.


Recruitment information / eligibility

Status Recruiting
Enrollment 3200
Est. completion date December 31, 2022
Est. primary completion date December 31, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - A head computed tomography (CT) scan following head trauma - Age =18 Years - Anticoagulant and/or antiplatelet therapy Exclusion Criteria: - moderate or severe brain injury (GCS = 13 in the initial assessment in the ED) - concomitant severe thoracic trauma with hypoxia (satO2 < 90% room air) - active bleeding and/or hemodynamic instability - intracranial haemorrhage with features suggesting spontaneous bleeding

Study Design


Intervention

Diagnostic Test:
Computed tomography
Head computed tomography

Locations

Country Name City State
Italy Azienda Ospedale Università Padova Padova PD

Sponsors (2)

Lead Sponsor Collaborator
University of Padova University Hospital Padova

Country where clinical trial is conducted

Italy, 

Outcome

Type Measure Description Time frame Safety issue
Primary Diagnosis of intracranial hemorrhage Diagnosis of intracranial hemorrhage 30 days
Secondary Need for surgery at 30-days-follow-up Need for surgery at 30-days-follow-up 30 days
Secondary Mortality for traumatic brain injury at 30-days-follow up Mortality for traumatic brain injury at 30-days-follow up 30 days
See also
  Status Clinical Trial Phase
Completed NCT04741334 - Mild Head Injury, Antiplatelets, and Anticoagulants
Terminated NCT01430988 - Observational Study of the BrainScope® Ahead™ M-100 in UK Emergency Department Patients With Head Injury N/A
Completed NCT00860210 - Pilot Study Assessing the Feasibility of Treating Foot Drop With the Neurostep™ System. Phase 1
Completed NCT00409058 - Teen Online Problem Solving (TOPS) - An Online Intervention Following TBI N/A
Completed NCT00251108 - Fitness Training After Traumatic Brain Injury N/A
Completed NCT02881957 - Hypovitaminosis D in Neurocritical Patients Phase 2/Phase 3
Completed NCT02368366 - Comparative Effectiveness of Family Problem-Solving Therapy (F-PST) for Adolescent TBI N/A
Completed NCT02819778 - Study Assessing Evaluation of the Interest of Serum S100B Protein Determination in the Management of Pediatric Mild Traumatic Brain Injury N/A
Completed NCT01886222 - Randomized Controlled Trial of Long-term Mild Hypothermia for Severe Traumatic Brain Injury N/A
Recruiting NCT06015451 - Exercise in Postconcussion Symptoms and Posttraumatic Headache N/A
Completed NCT03314480 - REDucing Unnecessary Computed Tomography Imaging for MaxillOfacial INjury
Completed NCT05292690 - An Assistive Powered Wheelchair: Stage 2 Trial
Terminated NCT01961804 - PREVACT : Preventive REversal of Vitamine K Antagonist in Minor Craniocerebral Trauma Phase 3
Completed NCT00005004 - Brain Processing of Language Meanings N/A
Completed NCT05891522 - Pilot Study of the Use of a Portable Cranial Scanner in Intensive Care for Cerebro-injured Patients N/A
Completed NCT02776462 - Use of Eye Movement Tracking to Detect Oculomotor Abnormality in Traumatic Brain Injury Patients
Completed NCT00200135 - Financial and Clinical Impact of Repeal of the Pennsylvania Motorcycle Helmet Law N/A
Completed NCT00534157 - Study of Eye Pressure as a Predictor of Intracranial Pressure in the Acutely Head-Injured Population N/A
Recruiting NCT01633268 - Estimating Brain Biomechanics Using MRI
Completed NCT02442882 - The Acute Effect of Boxing on Balance, Neuropsychological, and Visual Functions N/A